Afficiency
Latest round
- Series A
Last raised
- Apr 2022
Total raised
- $7M
Investors
- 4
About Afficiency
Based in New York, US, and founded in 2018 by Mark Scafaro and Ravi Arasan, Afficiency operates as an Insurtech platform that helps with the end-to-end life insurance buying process. Afficiency offers life insurance products through its digital platform all via proprietary API. The products include term, whole life, disability, and universal life insurance - underwriting and policy quoting, and product design as well as reinsurance partnerships. Since its inception and until 2022, the company has generated a 1000% YOY revenue growth.
Who invested in Afficiency
4 investors across 1 round
See all investors in Afficiency
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 5, 2022
Amount
$7M
Investors
Questions about Afficiency
Who invested in Afficiency?
Afficiency has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Afficiency raised?
Afficiency has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Afficiency last raise money?
Afficiency's most recent round on record is a Series A, in Apr 2022.
What does Afficiency do?
Based in New York, US, and founded in 2018 by Mark Scafaro and Ravi Arasan, Afficiency operates as an Insurtech platform that helps with the end-to-end life insurance buying process.
Where is Afficiency headquartered?
Afficiency is headquartered in New York, US.
Which VCs invest in companies like Afficiency?
Among active investors with capital left to deploy, Radical Ventures, Ribbit Capital, TrueBridge Capital Partners and Tribe Capital back insurance companies at Afficiency's stage. Their profiles are linked below.
VCs backing insurance startups at Series A
Raising like Afficiency? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.